USPTO serial 88111827
ENOVANT TECHNOLOGIES
Reviewed by CopyMark Law Group
Reg. 5999691Status 711
- Filing date
- Status date
- Registration date
- Mar 3, 2020
- Examiner
- SWAIN, MICHELE LYNN
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ENOVANT TECHNOLOGIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JAMES D. WEINBERGER
JAMES D. WEINBERGER FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42ND STREET 17TH FLOORNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software using artificial intelligence for providing, analyzing and generating reports; computer software for providing, analyzing and generating reports; computer software for data processing; computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images, information; computer software for database integration; computer software for creating searchable databases of information and data; software for analytics in the fields of healthcare, pharmaceutical and biomedical research and development, clinical and post-market trials, and the provision of medical and healthcare services; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer search engine software for accessing and providing updated scientific, medical and clinical information, and news information of general interest; computer software for accessing, controlling and managing data and information related to healthcare services and patient medical information | SECTION 7(e) - CANCELLED | — |
| 035 | Business consulting services; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business advisory services, consultancy and information; market intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; professional business analysis and consultancy and statistical analysis in the fields of healthcare, biomedicine, pharmaceuticals, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and research evaluating epidemiological outcomes; providing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare from an on-line database; providing commercial and business contact information within the scientific research and medical communities to achieve advances in the field of healthcare; business networking services within the scientific research and medical communities to achieve advances in the field of healthcare; compilation of data, analysis of business data and professional business analysis in the field of pharmaceutical and biomedical research and development, clinical trials, post-market trials, epidemiological research, pharmacoepidemiological research, and healthcare; compilation of data, analysis of business data and professional business analysis for medical and healthcare for business purposes; providing reimbursement benchmarking information and other market intelligence to healthcare organizations; collecting and professional business analysis of claims data from healthcare organizations for business purposes; business services provided to the healthcare industry, namely, the collection, reporting, and professional business analysis of healthcare data for business purposes | SECTION 7(e) - CANCELLED | — |
| 036 | Financial analysis; financial consulting; financial valuations and forecasting; financial analysis, namely, compiling and analyzing statistics and data for financial purposes; financial analysis of investments in pharmaceutical and biomedical research and development, and clinical and post-market trials; financial evaluation, tracking, analysis, forecasting, consultancy, advisory and research services relating to securities and other financial instruments; financial research related to financial instruments | SECTION 7(e) - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research and analysis, and diagnostic services in the field of pharmaceuticals and biomedicine; industrial analysis and research services in the field of pharmaceuticals and biomedicine; design and development of computer hardware and software; data processing analysis services; analysis of scientific data; pharmaceutical and biomedical research services; conducting clinical trials and post-market trials; epidemiological research services, pharmacoepidemiological research services; providing temporary use of non-downloadable software applications accessible via a web site regarding analytics of data for use in the fields of healthcare, pharmaceuticals, biomedicine, clinical trials, post-market trials, epidemiological research, and pharmacoepidemiological research; providing on-line information in the fields of pharmaceutical research, biomedical research, epidemiological research, pharmacoepidemiological research, and clinical trial and post-market trial data via a computer database or the Internet; providing scientific research information in the fields of healthcare, biomedicine, pharmaceuticals, and clinical and post-market clinical trials; providing temporary use of non-downloadable software applications accessible via a web site for data analytics and financial analytics for use in the fields of pharmaceutical and biomedical research and development, clinical trials, and the provision of medical and healthcare services; compiling data for research and analysis for medical science purposes in the field of healthcare, pharmaceuticals, biomedicine, clinical trials and post-market trials | SECTION 7(e) - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Roivant Sciences GmbH
- Other trademarks owned by Roivant Sciences GmbH
- Other trademarks owned by Roivant Sciences GmbH
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Similar marks named ENOVANT TECHNOLOGIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2021 | C7.. | CANCELLED SECTION 7-TOTAL | — |
| Sep 8, 2021 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Sep 8, 2021 | CAND | CANCELLATION DENIED NO. 999999 | — |
| Jun 15, 2021 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Mar 3, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 17, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 17, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 13, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 29, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 29, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 29, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 29, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 3, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 15, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 16, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2018 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Sep 30, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 20, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Sep 18, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 14, 2018 | NWAP | NEW APPLICATION ENTERED | — |